Jonathan J. Waataja
ReShape Lifesciences (United States)
ORCID: 0009-0000-3917-0865NeuroscienceMedicine
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested β papers, authors, and institutions outside the pilot are not represented. Methodology.
Top 100%percentile
Indexed papers
0in pilot corpus
Papers
Driven by 2 papers. Top paper: βUse of a bio-electronic device comprising of targeted dual neuromodulation of the hepatic and celiac vagal branches demonstrated enhanced glycemic control in a type 2 diabetic rat model as well as in an Alloxan treated swine modelβ.
10 citations
Raj K. Nihalani, Chris N. Honda, Charles J. Billington, Jonathan J. Waataja
8 citations
Anders J. Asp, Charles J. Billington, Jonathan J. Waataja